ABSTRACT
An 84-year-old man visited our hospital with a high fever. He had cut his right index finger 7 days previously. Blood culture became positive on day 3. Gram staining was negative, and acid-fast staining was positive. The organism was subsequently identified as Mycobacterium obuense using a MALDI Biotyper. M. obuense was also detected in the soil at the patient's house, suggesting that it had entered his bloodstream through the cut on his finger. He was treated with a combination of imipenem/cilastatin, amikacin, and clarithromycin for 2 weeks. His clinical condition improved, and he was discharged after 2 weeks and was prescribed clarithromycin and levofloxacin therapy. Only two cases of human infection with M. obuense have been reported previously.
Subject(s)
Bacteremia , Mycobacterium Infections, Nontuberculous , Male , Humans , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Nontuberculous Mycobacteria , Clarithromycin/therapeutic use , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/etiology , Bacteremia/diagnosis , Bacteremia/drug therapy , Bacteremia/complicationsABSTRACT
We herein report a case of peritoneal dialysis-associated peritonitis caused by Lysinibacillus sphaericus in a 40s-year-old patient. Treatment was initiated with intermittent intraperitoneal cefazolin and ceftazidime. Later, both peritoneal dialysate and blood cultures detected L. sphaericus, so the antibiotic was changed to ampicillin (ABPC). The patient was treated with a combination of intraperitoneal intermittent and intravenous ABPC for 7 days, followed by 14 days of amoxicillin. The patient experienced no adverse events and no recurrence for 30 days. The patient had four dogs, and the infection was deemed likely to have been caused by environmental contamination and inadequate catheter replacement.
Subject(s)
Anti-Bacterial Agents , Peritoneal Dialysis, Continuous Ambulatory , Peritoneal Dialysis , Peritonitis , Adult , Humans , Ampicillin , Anti-Bacterial Agents/therapeutic use , Peritoneal Dialysis/adverse effects , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/drug therapy , Peritonitis/etiologyABSTRACT
Staphylococcus saprophyticus is a gram-positive, coagulase-negative member of the Staphylococcus genus and is second only to Escherichia coli as a cause of urinary tract infections in the young female population. S. saprophyticus usually has good susceptibility to drugs commonly used to treat urinary tract infections, but it is often methicillin-resistant. Here we report a case of acute focal bacterial nephritis in a 13-year-old female patient caused by methicillin-resistant S. saprophyticus and treated with daptomycin (DAP). The patient had a history of unilateral hearing loss and presented to her previous physician with a 3-day history of fever, right-sided abdominal pain, and diarrhea. Cefotaxime antimicrobial chemotherapy was initiated as an empiric therapy targeting E. coli, the most frequent cause of community-onset pyelonephritis. Vancomycin (VCM) was started for acute focal bacterial nephritis caused by methicillin-resistant S. saprophyticus but was stopped due to allergy and replaced with DAP. After 13 days of treatment with DAP, the patient received 17 days of treatment with sulfamethoxazole-trimethoprim combination therapy. The patient experienced no adverse events and did not relapse. DAP is a relatively new anti-methicillin-resistant Staphylococcus aureus drug used to treat gram-positive cocci infections. It is primarily excreted by the kidneys, which may be desirable in treating urinary tract infections. For children who cannot receive VCM for any reason, DAP may be a viable alternative.
